| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |